Autori: Stupp Roger
Naslov | Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial (Article) |
Autori | Stupp Roger ... Grujicic Danica M ... (broj koautora 37) |
Info | LANCET ONCOLOGY, (2014), vol. 15 br. 10, str. 1100-1108 |
Projekat | Merck KGaA, Darmstadt, Germany |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |